Answers for Canadian health & life science founders

What non-dilutive funding is available for Canadian healthcare startups?

There is considerably more non-dilutive money available to Canadian health founders than most of them think. The reason it doesn't feel that way is that the programmes are scattered, the eligibility rules are buried, and — the part that catches people out — most of it pays you back rather than paying you forward.

The two facts that decide whether a programme is useful to you

Before the award size, before the success rate, before the case study on the programme's website, get these two straight for every programme on your list:

  1. Up front, reimbursement, or tax credit? These are three genuinely different products wearing similar language. Only one of them puts money in your account before you spend it.
  2. What must you bring? A cash match, an academic partner, in-province spending, a minimum headcount. The stated eligibility line is rarely the real gate.

The federal programmes most Canadian health startups should know

SR&ED — the Scientific Research and Experimental Development tax credit. Refunds up to roughly 35% of eligible R&D spending for Canadian-controlled private corporations, and you can claim it with no revenue at all. It is the largest single source of innovation funding in the country. The timing: you claim it when you file your corporate taxes, so the money arriving this year repays work you paid for last year. Always one lap behind you.

NRC IRAP — the Industrial Research Assistance Program. Reimburses a share of the salaries of technical staff working on an approved project, and assigns you an Industrial Technology Advisor, who is frequently worth more than the money: ITAs tend to know every other funding door in your region. It stacks with SR&ED. The timing: reimbursement. You pay the salaries first.

Mitacs — internship funding pairing you with academic researchers, with intellectual-property terms friendlier than most founders expect. The catch is structural: it needs a university research partner and, in the standard arrangement, $7,500 of your own cash per internship unit. Matching money, not free money. Excellent if you have a collaborator or want an excuse to acquire one; not a real option this quarter if you have neither the partner nor the match.

Innovative Solutions Canada — federal departments buying solutions to stated problems. Different in kind from the three above, because it is procurement rather than a grant, and a government customer is a different sort of asset than a cheque.

The provincial layer, which is where founders under-search

What is available changes enormously depending on where you are incorporated — Genome BC in the west, FACIT in Ontario, and a long tail of programmes with real money and modest public profiles. Provincial money is frequently the least competitive on the list, because fewer founders know it exists. It is also the layer most likely to have changed since the last time anyone looked, which is why we re-verify on a rolling monthly cycle rather than publishing a list and walking away.

So which ones apply to you?

That depends on your stage, your sector, your province, and whether you have an academic partner — which is precisely the problem, because it means the answer is different for every founder and no general list can give it to you.

We track 63 verified programmes, each one checked against the source by a person and date-stamped, with the cash timing and the match requirement recorded for every single entry — so that no founder has to rebuild this spreadsheet from scratch.

If you are ready to move from general education to actionable insight for your own company, consider your own Capital Roadmap. 159 verified investors and 63 non-dilutive programmes, filtered to your stage, sector and province, with everyone you have already pitched removed — and a guarantee of at least five qualified investors you have not approached, or your money back.

See what matches your company →

Information, not advice. Profiles are compiled from public sources and verified on the date shown; always confirm details with the source before relying on them.